Published Articles on Vitiligo from January through December 2010

Below you will find a list of published articles on vitiligo, subdivided into Review Articles, Clinical Articles, and Basic Science Articles. Each article is linked to its listing in PubMed. Please note that, due to copyright restrictions, the National Vitiligo Foundation can not provide a direct link to the full text or PDF version of the article.

To go back to viewing the most recent articles, click here.

Review Articles

DECEMBER 2010

Kim DY, Oh SH, Hann SK. Classification of segmental vitiligo on the face: Clues for prognosis. Br J Dermatol. 2010 Dec 27.

Bilgiç O, Bilgiç A, Akiş HK, Eskioğlu F, Kiliç EZ. Depression, anxiety and health-related quality of life in children and adolescents with vitiligo. Clin Exp Dermatol. 2010 Dec 24.

Arunachalam M, Sanzo M, Lotti T, Colucci R, Berti S, Moretti S. Common variable immunodeficiency in vitiligo. G Ital Dermatol Venereol. 2010 Dec;145(6):783-8.

Batalla A, Feal JC. Linear Vitiligo Going on a Varix Way: Possible Association with Koebner Phenomenon. Actas Dermosifiliogr. 2010 Dec;101(10):902-903.

Arunachalam M, Sanzo M, Lotti T, Colucci R, Berti S, Moretti S. Common variable immunodeficiency in vitiligo. G Ital Dermatol Venereol. 2010 Dec;145(6):783-8.

Eleftheriadou V, Whitton ME, Gawkrodger DJ, Batchelor J, Corne J, Lamb B, Ersser S, Ravenscroft J, Thomas KS; on behalf of the vitiligo priority setting partnership. Future research into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership. Br J Dermatol. 2010 Dec 3.

Paterson E. Vitiligo. J Vis Commun Med. 2010 Dec;33(4):166-8.


NOVEMBER 2010

Hwang SW, Kang JH, Jung SY, Choi JH, Seo JK, Lee D, Sung HS. Vitiligo Coexistent with Nevus Depigmentosus: This Was Treated with Narrow-Band UVB and These Lesions Were Followed Using the Mexameter®, a Pigment-Measuring Device. Ann Dermatol. 2010 Nov;22(4):482-5.

Kanwar A, Parsad D, De D. Mucosal involvement in vitiligo: a comprehensive review of 241 cases. J Eur Acad Dermatol Venereol. 2010 Nov 25.

Bhalla M, Thami GP. Factors predicting the preference of complementary and alternative systems of medicine in treatment of vitiligo. Indian J Dermatol Venereol Leprol. 2010 Nov-Dec;76(6):705-7.

Alghamdi K, Kumar A. Depigmentation therapies for normal skin in vitiligo universalis. J Eur Acad Dermatol Venereol. 2010 Nov 4.


OCTOBER 2010

Spritz RA. The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma. Genome Med. 2010 Oct 19;2(10):78.

AlGhamdi KM. Beliefs and perceptions of Arab vitiligo patients regarding their condition. Int J Dermatol. 2010 Oct;49(10):1141-5.

Majid I. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study. Photodermatol Photoimmunol Photomed. 2010 Oct;26(5):230-4.

Mashayekhi V, Javidi Z, Kiafar B, Manteghi AA, Saadatian V, Esmaeili HA, Hosseinalizadeh S. Quality of life in patients with vitiligo: a descriptive study on 83 patients attending a PUVA therapy unit in Imam Reza Hospital, Mashad. Indian J Dermatol Venereol Leprol. 2010 Sep-Oct;76(5):592.

Pahwa M, Gupta S, Khunger N. Multimodal single-step vitiligo surgery: a novel approach. Dermatol Surg. 2010 Oct;36(10):1627-31.


AUGUST 2010

Viles J, Monte D, Gawkrodger DJ. Vitiligo. BMJ. 2010 Aug 20;341.

Gawkrodger DJ, Ormerod AD, Shaw L, Mauri-Sole I, Whitton ME, Watts MJ, Anstey AV, Ingham J, Young K. Vitiligo: concise evidence based guidelines on diagnosis and management. Postgrad Med J. 2010 Aug;86(1018):466-71.

Silverberg NB. Update on childhood vitiligo. Curr Opin Pediatr. 2010 Aug;22(4):445-52.


JULY 2010

Wang KY, Wang KH, Zhang ZP. Health-related quality of life and marital quality of vitiligo patients in China. J Eur Acad Dermatol Venereol. 2010 Jul 28.

Spritz RA. Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease. Thyroid. 2010 Jul;20(7):745-54.


JUNE 2010

Tamesis ME, Morelli JG. Vitiligo Treatment in Childhood: A State of the Art Review. Pediatr Dermatol. 2010 Jun 9.

Guerra L, Dellambra E, Brescia S, Raskovic D. Vitiligo: pathogenetic hypotheses and targets for current therapies. Curr Drug Metab. 2010 Jun 1;11(5):451-67.

Mazereeuw-Hautier J, Bezio S, Mahe E, Bodemer C, Eschard C, Viseux V, Labreze C, Plantin P, Barbarot S, Vabres P, Martin L, Paul C, Lacour JP; Groupe de Recherche Clinique en Dermatologie Pédiatrique (GRCDP). Segmental and nonsegmental childhood vitiligo has distinct clinical characteristics: a prospective observational study. J Am Acad Dermatol. 2010 Jun;62(6):945-9.


MAY 2010

Bowen C, Kobayashi TT. What is your diagnosis? Segmental vitiligo and en coup de sabre. Cutis. 2010 May;85(5):230, 237-8.

Ingordo V, Gentile C, Iannazzone S, Cusano F, Naldi L. Vitiligo and autoimmunity: an epidemiological study in a representative sample of young Italian males. J Eur Acad Dermatol Venereol. 2010 May 7.

Abu Tahir M, Pramod K, Ansari SH, Ali J. Current remedies for vitiligo. Autoimmun Rev. 2010 May;9(7):516-20.


APRIL 2010

Perossini M, Turio E, Perossini T, Cei G, Barachini P. Vitiligo: ocular and electrophysiological findings. G Ital Dermatol Venereol. 2010 Apr;145(2):141-9.

Cho SB, Kim JH, Cho S, Park JM, Park YK, Oh SH. Vitiligo in children and adolescents: association with thyroid dysfunction. J Eur Acad Dermatol Venereol. 2010 Apr 28.

Thompson AR, Clarke SA, Newell RJ, Gawkrodger DJ; The Appearance Research Collaboration (ARC). Vitiligo linked to stigmatization in British South Asian women: A qualitative study of the experiences of living with vitiligo. Br J Dermatol. 2010 Apr 26.


MARCH 2010

Tanioka M, Yamamoto Y, Kato M, Miyachi Y. Camouflage for patients with vitiligo vulgaris improved their quality of life. J Cosmet Dermatol. 2010 Mar;9(1):72-5.

Phd RC, Msc MP, Phd WP, Phd BZ, Msc TT, Febu TD. Transplantation of cultured autologous melanocytes - hope or danger? Cell Transplant. 2010 Mar 26.

Patel N, O'Haver J, Hansen RC. Vitiligo Therapy in Children: A Case for Considering Excimer Laser Treatment. Clin Pediatr (Phila). 2010 Mar 22.

Radtke MA, Schäfer I, Gajur AI, Augustin M. Clinical features and treatment outcomes of vitiligo from the patients' perspective: results of a national survey in Germany. Dermatology. 2010;220(3):194-200.

Albert DM. Melanoma, vitiligo, and uveitis. Ophthalmology. 2010 Mar;117(3):643-4.

Smith AG, Sturm RA. Multiple genes and locus interactions in susceptibility to vitiligo. J Invest Dermatol. 2010 Mar;130(3):643-5.


FEBRUARY 2010

Holla AP, Parsad D. Vitiligo surgery: its evolution as a definite treatment in the stable vitiligo. G Ital Dermatol Venereol. 2010 Feb;145(1):79-88.

Hossani-Madani AR, Halder RM. Topical treatment and combination approaches for vitiligo: new insights, new developments. G Ital Dermatol Venereol. 2010 Feb;145(1):57-78.

Akay BN, Bozkir M, Anadolu Y, Gullu S. Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey. J Eur Acad Dermatol Venereol. 2010 Feb 25.

Hossani-Madani AR, Halder RM. Topical treatment and combination approaches for vitiligo: new insights, new developments. G Ital Dermatol Venereol. 2010 Feb;145(1):57-78.

Abu Tahir M, Pramod K, Ansari SH, Ali J. Current remedies for vitiligo. Autoimmun Rev. 2010 Feb 8.


JANUARY 2010

Whitton ME, Pinart M, Batchelor J, Lushey C, Leonardi-Bee J, González U. Interventions for vitiligo. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003263.


Return to top of page

Clinical Articles

DECEMBER 2010

Santaguida MG, Del Duca SC, Virili C, Gargano L, Centanni M. The presence of non-segmental vitiligo modifies intracellular cytokine subsets in patients with chronic lymphocytic thyroiditis. Int J Immunopathol Pharmacol. 2010 Oct-Dec;23(4):1203-9.

El-Khateeb EA, Ragab NF, Mohamed SA. Epidermal photoprotection: comparative study of narrowband ultraviolet B minimal erythema doses with and without stratum corneum stripping in normal and vitiligo skin. Clin Exp Dermatol. 2010 Dec 24.

Czarnowicki T, Harari M, Ruzicka T, Ingber A. Dead Sea climatotherapy for vitiligo: a retrospective study of 436 patients. J Eur Acad Dermatol Venereol. 2010 Dec 5.

Lee DY, Kim CR, Lee JH, Yang JM. Recent onset vitiligo treated with systemic corticosteroid and topical tacrolimus: Need for early treatment in vitiligo. J Dermatol. 2010 Dec;37(12):1057-9.

Eves PC, Baran M, Bullett NA, Way L, Haddow D, Neil SM. Establishing a Transport Protocol for the Delivery of Melanocytes and Keratinocytes for the Treatment of Vitiligo. Tissue Eng Part C Methods. 2010 Dec 7.

van Geel N, Wallaeys E, Goh BK, De Mil M, Lambert J. Long-term results of noncultured epidermal cellular grafting in vitiligo, halo naevi, piebaldism and naevus depigmentosus. Br J Dermatol. 2010 Dec;163(6):1186-93.


NOVEMBER 2010

Van Geel N, Vandenhaute S, Speeckaert R, Brochez L, Mollet I, De Cooman L, Lambert J. Prognostic value and clinical significance of halo nevi regarding vitiligo. Br J Dermatol. 2010 Nov 29.

Yu WT, Yu HS, Wu CS, Lee CH, Cheng YC, Lin WT, Chen GS, Lan CC. Noninvasive cutaneous blood flow assessment as a response predictor for visible light therapy on segmental vitiligo: A prospective pilot study. Br J Dermatol. 2010 Nov 18.

Singh A, Kornmehl H, Milgraum S. Segmental vitiligo following encephalitis. Pediatr Dermatol. 2010 Nov;27(6):624-5.

Ganzetti G, Simonetti O, Campanati A, Giuliodori K, Offidani A. Phototherapy as a useful therapeutic option in the treatment of diphenylcyclopropenone-induced vitiligo. Acta Derm Venereol. 2010 Nov;90(6):642-3.

Kang HY, le Duff F, Passeron T, Lacour JP, Ortonne JP, Bahadoran P. A noninvasive technique, reflectance confocal microscopy, for the characterization of melanocyte loss in untreated and treated vitiligo lesions. J Am Acad Dermatol. 2010 Nov;63(5):e97-100.


OCTOBER 2010

AlGhamdi KM. Beliefs and perceptions of Arab vitiligo patients regarding their condition. Int J Dermatol. 2010 Oct;49(10):1141-5.

Majid I. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study. Photodermatol Photoimmunol Photomed. 2010 Oct;26(5):230-4.

Kim T, Roh HJ, Kim JY, Noh S, Oh SH. Rapid formation of suction blister through intradermal injection of local anesthetics in epidermal graft for vitiligo. Dermatol Surg. 2010 Oct;36(10):1642-3.

Wind B, Meesters A, Kroon M, Beek J, Van Der Veen J, Nieuweboer-Krobotová L, Bos J, Wolkerstorfer A. Punchgraft testing in vitiligo; effects of UVA, NB-UVB and nm Helium-Neon laser on the outcome. 632.8 J Eur Acad Dermatol Venereol. 2010 Oct 6.

Asawanonda P, Klahan SO. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study. Photomed Laser Surg. 2010 Oct;28(5):679-84.


SEPTEMBER 2010

BinSaif GA, Al Samary A, Al Mohizea S. Failure of botulinum toxin treatment for localized vitiligo. J Drugs Dermatol. 2010 Sep;9(9):1092-4.

Van Geel N, De Lille S, Vandenhaute S, Gauthier Y, Mollet I, Brochez L, Lambert J. Different phenotypes of segmental vitiligo based on a clinical observational study. J Eur Acad Dermatol Venereol. 2010 Sep 14.

Mashayekhi V, Javidi Z, Kiafar B, Manteghi AA, Saadatian V, Esmaeili HA, Hosseinalizadeh S. Quality of life in patients with vitiligo: a descriptive study on 83 patients attending a PUVA therapy unit in Imam Reza Hospital, Mashad. Indian J Dermatol Venereol Leprol. 2010 Sep-Oct;76(5):592.


AUGUST 2010

van Geel N, Wallaeys E, Goh BK, De Mil M, Lambert J. Long term results of non cultured epidermal cellular grafting in vitiligo, halo nevi, piebaldism and nevus depigmentosus. Br J Dermatol. 2010 Aug 28.

Kahn AM, Applebaum R. Operative Treatment for Segmental Eyelid Vitiligo. Ophthal Plast Reconstr Surg. 2010 Aug 23.

Pahwa M, Gupta S, Khunger N. Multimodal Single-Step Vitiligo Surgery: A Novel Approach. Dermatol Surg. 2010 Aug 16.

Shin JW, Nam KM, Choi HR, Huh SY, Kim SW, Youn SW, Huh CH, Park KC. Erythrocyte malondialdehyde and glutathione levels in vitiligo patients. Ann Dermatol. 2010 Aug;22(3):279-83.

Cervelli V, Spallone D, Lucarini L, Palla L, Brinci L, De Angelis B. Treatment of stable vitiligo hands by ReCell system: a preliminary report. Eur Rev Med Pharmacol Sci. 2010 Aug;14(8):691-4.

El-Mofty M, Mostafa WZ, Bosseila M, Youssef R, Esmat S, El Ramly A, Fawzi M, Mahgoub D, Nagui N, Mashaly HM, El-Fangary M, Fathy M. A large scale analytical study on efficacy of different photo(chemo)therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides. Dermatol Ther. 2010 Jul-Aug;23(4):428-34.

Gonul M, Cakmak SK, Soylu S, Kilic A, Gul U. Serum vitamin B12, folate, ferritin and iron levels in Turkish patients with vitiligo. Indian J Dermatol Venereol Leprol. 2010 Jul-Aug;76(4):448.

Nishitani N, Bito T, Ikeda T, Tokura Y, Nishigori C. Complete remission of metastatic malignant melanoma after surgery in association with development of systemic vitiligo. J Dermatol. 2010 Aug;37(8):770-2.

Park JM, Kim HJ, Bae BG, Park YK. A case of concurrent vitiligo and psoriasis. Ann Dermatol. 2009 Aug;21(3):330-3.


JULY 2010

Hong W, Hu DN, Qian GP, McCormick SA, Xu AE. Treatment of vitiligo in children and adolescents by autologous cultured pure melanocytes transplantation with comparison of efficacy to results in adults. J Eur Acad Dermatol Venereol. 2010 Jul 29.

Shin JU, Roh MR, Lee JH. Vitiligo following intense pulsed light treatment. J Dermatol. 2010 Jul;37(7):674-6.

Lee DY, Park JH, Lee JH, Yang JM, Lee ES. The poor response of phototherapy in old lesions of vitiligo may be related to the presence of white hairs: a hypothesis. Photodermatol Photoimmunol Photomed. 2010 Aug;26(4):219-20.

Rustemeyer J, Günther L, Deichert L. A rare association: basal cell carcinoma in a vitiliginous macula. Oral Maxillofac Surg. 2010 Jul 11.


JUNE 2010

Parsad D, Kanwar A. Oral minocycline in the treatment of vitiligo--a preliminary study. Dermatol Ther. 2010 May-Jun;23(3):305-7.

El-Zawahry BM, Zaki NS, Bassiouny DA, Sobhi RM, Zaghloul A, Khorshied MM, Gouda HM. Autologous melanocyte-keratinocyte suspension in the treatment of vitiligo. J Eur Acad Dermatol Venereol. 2010 Jun 21.

van Geel N, Wallaeys E, Goh BK, De Mil M, Lambert J. Long term results of non cultured epidermal cellular grafting in vitiligo, halo nevi, piebaldism and nevus depigmentosus. Br J Dermatol. 2010 Jun 19.

Alkhateeb A, Qarqaz F, Al-Sabah J, Al Rashaideh T. Clinical Characteristics and PTPN22 1858C/T Variant Analysis in Jordanian Arab Vitiligo Patients. Mol Diagn Ther. 2010 Jun;14(3):179-84.

Pires MC, Martins JM, Montealegre F, Gatti FR. Vitiligo after diphencyprone for alopecia areata. Dermatol Res Pract. 2010;2010:171265.

Zhang XY, He YL, Dong J, Xu JZ, Wang J. Clinical efficacy of a 308 nm excimer laser in the treatment of vitiligo. Photodermatol Photoimmunol Photomed. 2010 Jun;26(3):138-42.

Cho EA, Lee MA, Kang H, Lee SD, Kim HO, Park YM. Vitiligo-like Depigmentation Associated with Metastatic Melanoma of an Unknown Origin. Ann Dermatol. 2009 May;21(2):178-81.


MAY 2010

Jung JY, Yeom KB, Eun HC. Chemical Leukoderma Improved by Low-dose Steroid Pulse Therapy. Ann Dermatol. 2010 May;22(2):241-4. Epub 2010 May 19.

Lee DY, Lee JH. White hairs in segmental vitiligo are related to poor response to phototherapy: demonstration with portable digital microscopy. J Dermatol. 2010 May;37(5):500-1.

Choi KW, Kim KH, Kim YH. Comparative Study of the Gross Interpretation of Phototesting and Objective Measurement with Using a Spectrophotometer for Patients with Psoriasis and Vitiligo Treated with Narrow-band UVB. Ann Dermatol. 2009 May;21(2):136-41.

de Leeuw J, Assen YJ, van der Beek N, Bjerring P, Martino Neumann HA. Treatment of vitiligo with khellin liposomes, ultraviolet light and blister roof transplantation. J Eur Acad Dermatol Venereol. 2010 May 7.

Majid I. Topical placental extract: does it increase the efficacy of narrowband UVB therapy in vitiligo? Indian J Dermatol Venereol Leprol. 2010 May-Jun;76(3):254-8.

Garg BJ, Saraswat A, Bhatia A, Katare OP. Topical treatment in vitiligo and the potential uses of new drug delivery systems. Indian J Dermatol Venereol Leprol. 2010 May-Jun;76(3):231-8.

Bahmani M, Fallahzadeh MK, Jowkar F, Khalesi M, Bahri-Najafi R, Namazi MR. Can topical phenytoin augment the therapeutic efficacy of PUVA against vitiligo? A double-blind, randomized, bilateral-comparison, placebo-controlled study. J Dermatolog Treat. 2010 May 5.

Köse O, Arca E, Kurumlu Z. Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo. J Dermatolog Treat. 2010 May;21(3):133-9.

Wind BS, Kroon MW, Beek JF, van der Veen JP, Nieuweboer-Krobotová L, Meesters AA, Bos JD, Wolkerstorfer A. Home vs. outpatient narrowband ultraviolet B therapy for the treatment of nonsegmental vitiligo: a retrospective questionnaire study. Br J Dermatol. 2010 May;162(5):1142-4.


APRIL 2010

Al-Mutairi N, Manchanda Y, Al-Doukhi A, Al-Haddad A. Long-term results of split-skin grafting in combination with excimer laser for stable vitiligo. Dermatol Surg. 2010 Apr;36(4):499-505.

Lee DY, Lee JH. Epidermal grafting for vitiligo: a comparison of cultured and noncultured grafts. Clin Exp Dermatol. 2010 Apr;35(3):325-6.

Gamil H, Attwa E, Ghonemy S. Narrowband ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of generalized vitiligo. Clin Exp Dermatol. 2010 Apr 26.

Lee DY, Lee KJ, Choi SC, Lee JH. Segmental vitiligo treated by the combination of epidermal grafting and systemic corticosteroids. Dermatol Surg. 2010 Apr;36(4):575-6.

Lee DY, Park JH, Lee JH, Yang JM, Lee ES. Surgical treatment is indicated in long-duration segmental vitiligo. Dermatol Surg. 2010 Apr;36(4):568-9.

Amerio P, Di Rollo D, Carbone A, Auriemma M, Marra ME, De Remigis P, Feliciani C, Tracanna M, Tulli A. Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases. Eur J Dermatol. 2010 May-Jun;20(3):354-8. Epub 2010 Apr 16.

Khodadadi L, Shafieyan S, Sotoudeh M, Dizaj AV, Shahverdi A, Aghdami N, Baharvand H. Intraepidermal injection of dissociated epidermal cell suspension improves vitiligo. Arch Dermatol Res. 2010 Apr 4.

Murase JE, Koo JY, Berger TG. Narrowband ultraviolet B phototherapy influences serum folate levels in patients with vitiligo. J Am Acad Dermatol. 2010 Apr;62(4):710-1.


MARCH 2010

Yang YS, Cho HR, Ryou JH, Lee MH. Clinical study of repigmentation patterns with either narrow-band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients. Int J Dermatol. 2010 Mar;49(3):317-23.

Di Nuzzo S, Masotti A. Depigmentation therapy in vitiligo universalis with cryotherapy and 4-hydroxyanisole. Clin Exp Dermatol. 2010 Mar;35(2):215-6.

Lee DY, Park JH, Lee JH, Yang JM, Lee ES. Recurrence of segmental vitiligo after epidermal grafting does not involve epidermal grafting area. Clin Exp Dermatol. 2010 Mar;35(2):205-6.

Le Duff F, Fontas E, Giacchero D, Sillard L, Lacour JP, Ortonne JP, Passeron T. 308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study. Br J Dermatol. 2010 Mar 23.

Seo I, Baqer A, Kollias N. The effect of visible light and near-infrared radiation on constitutive pigment of patients with vitiligo. Br J Dermatol. 2010 Mar 10.

Radtke MA, Schäfer I, Gajur AI, Augustin M. Clinical Features and Treatment Outcomes of Vitiligo from the Patients' Perspective: Results of a National Survey in Germany. Dermatology. 2010 Mar 5.

Wind BS, Kroon MW, Beek JF, van der Veen JP, Nieuweboer-Krobotová L, Meesters AA, Bos JD, Wolkerstorfer A. Home vs. outpatient narrowband ultraviolet B therapy for the treatment of nonsegmental vitiligo: a retrospective questionnaire study. Br J Dermatol. 2010 Mar 1.

Mchepange UO, Gao XH, Liu YY, Liu YB, Ma L, Zhang L, Chen HD. Vitiligo in North-Eastern China: An association between mucosal and acrofacial lesions. Acta Derm Venereol. 2010 Mar;90(2):136-40.


FEBRUARY 2010

Holla AP, Parsad D. Vitiligo surgery: its evolution as a definite treatment in the stable vitiligo. G Ital Dermatol Venereol. 2010 Feb;145(1):79-88.

Liu J, Man WY, Lv CZ, Song SP, Shi YJ, Elias PM, Man MQ. Epidermal Permeability Barrier Recovery Is Delayed in Vitiligo-Involved Sites. Skin Pharmacol Physiol. 2010 Feb 25;23(4):193-200.

Al-Mutairi N, Manchanda Y, Al-Doukhi A, Al-Haddad A. Long-Term Results of Split-Skin Grafting in Combination with Excimer Laser for Stable Vitiligo. Dermatol Surg. 2010 Feb 17.

Lo YH, Cheng GS, Huang CC, Chang WY, Wu CS. Efficacy and safety of topical tacrolimus for the treatment of face and neck vitiligo. J Dermatol. 2010 Feb;37(2):125-9.


JANUARY 2010

Tanioka M, Yamamoto Y, Katoh M, Takahashi K, Miyachi Y. Vitiligo vulgaris and autoimmune diseases in Japan: A report from vitiligo clinic in Kyoto University Hospital. Dermatoendocrinol. 2009 Jan;1(1):43-5.

Ali R, Ahsan MS, Azad MA, Ullah MA, Bari W, Islam SN, Yeasmin S, Hasnat A. Immunoglobulin levels of vitiligo patients. Pak J Pharm Sci. 2010 Jan;23(1):97-102.

Yan DM, Chang YX, Wang YF, Liu EW, Li J, Kang LY, Gao XM. In vivo pharmacokinetics of bakuchiol after oral administration of bakuchiol extraction in rat plasma. J Ethnopharmacol. 2010 Jan 5.


Return to top of page

Basic Science Articles

DECEMBER 2010

Prignano F, Ricceri F, Bianchi B, Guasti D, Bonciolini V, Lotti T, Pimpinelli N. Dendritic cells: ultrastructural and immunophenotypical changes upon nb-UVB in vitiligo skin. Arch Dermatol Res. 2010 Dec 21.

Zhou Q, Wang F, Zhang Y, Yang F, Wang Y, Sun S. Down-regulation of Prdx6 contributes to DNA vaccine induced vitiligo in mice. Mol Biosyst. 2010 Dec 10.

Kim NH, Lee AY. Histamine effect on melanocyte proliferation and vitiliginous keratinocyte survival. Exp Dermatol. 2010 Dec;19(12):1073-9.


NOVEMBER 2010

Liu L, Li C, Gao J, Li K, Zhang R, Wang G, Li C, Gao T. Promoter variant in the catalase gene is associated with vitiligo in chinese people. J Invest Dermatol. 2010 Nov;130(11):2647-53.

Douroudis K, Kingo K, Karelson M, Silm H, Reimann E, Traks T, Vasar E, Kõks S. The PRO2268 Gene as a Novel Susceptibility Locus for Vitiligo. Acta Derm Venereol. 2010 Nov 22.

Li Q, Lv Y, Li C, Yi X, Long HA, Qiao H, Lu T, Luan Q, Li K, Wang X, Wang G, Gao T. Vitiligo Autoantigen VIT75 Is Identified as Lamin A in Vitiligo by Serological Proteome Analysis Based on Mass Spectrometry. J Invest Dermatol. 2010 Nov 18.

Birlea SA, Jin Y, Bennett DC, Herbstman DM, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Fain PR, Spritz RA. Comprehensive Association Analysis of Candidate Genes for Generalized Vitiligo Supports XBP1, FOXP3, and TSLP. J Invest Dermatol. 2010 Nov 18.

Lin X, Tian H, Xianmin M. Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity. Med Hypotheses. 2010 Nov 12.

Lv Y, Liao W, Luan Q, Wang H, Wang L, Li Q. The polymorphism of catalase T/C codon 389 in exon 9 and vitiligo susceptibility: a meta-analysis. J Eur Acad Dermatol Venereol. 2010 Nov 4.

Alkhateeb A, Al-Dain Marzouka N, Qarqaz F. SMOC2 gene variant and the risk of vitiligo in Jordanian Arabs. Eur J Dermatol. 2010 Nov-Dec;20(6):701-4.

Reimann E, Kingo K, Karelson M, Salum T, Aunin E, Reemann P, Abram K, Vasar E, Silm H, Kõks S. Analysis of the expression profile of CRH-POMC system genes in vitiligo skin biopsies. J Dermatol Sci. 2010 Nov;60(2):125-8.


OCTOBER 2010

Alkhateeb A, Qarqaz F. Genetic association of NALP1 with generalized vitiligo in Jordanian Arabs. Arch Dermatol Res. 2010 Oct;302(8):631-4.

Zhao M, Gao F, Wu X, Tang J, Lu Q. Abnormal DNA methylation in peripheral blood mononuclear cells from patients with vitiligo. Br J Dermatol. 2010 Oct;163(4):736-42.

Lan CC, Wu CS, Chen GS, Yu HS. FK506 (topical tacrolimus) and Enothothelin Combined Treatment Induces Mobility of Melanoblasts: New Insights of Follicular Vitiligo Repigmentation Induced by Topical Tacrolimus on Sun-Exposed Skin. Br J Dermatol. 2010 Oct 29.


SEPTEMBER 2010

Takle GL, Suedmeyer WK, Garner MM. Diagnosis and treatment of vitiligo in a sub-adult eastern black rhinoceros (Diceros bicornis michaeli). J Zoo Wildl Med. 2010 Sep;41(3):545-9.


AUGUST 2010

Reimann E, Kingo K, Karelson M, Salum T, Aunin E, Reemann P, Abram K, Vasar E, Silm H, Kõks S. Analysis of the expression profile of CRH-POMC system genes in vitiligo skin biopsies. J Dermatol Sci. 2010 Aug 26.

Kingo K, Reimann E, Karelson M, Rätsep R, Raud K, Vasar E, Silm H, Kõks S. Association Analysis of Genes of the IL19 Cluster and Their Receptors in Vitiligo Patients. Dermatology. 2010 Aug 12.

Yun JY, Uhm YK, Kim HJ, Lim SH, Chung JH, Shin MK, Yim SV, Lee MH. Transforming growth factor beta receptor II (TGFBR2) polymorphisms and the association with nonsegmental vitiligo in the Korean population. Int J Immunogenet. 2010 Aug;37(4):289-91.


JULY 2010

Quan C, Ren YQ, Xiang LH, Sun LD, Xu AE, Gao XH, Chen HD, Pu XM, Wu RN, Liang CZ, Li JB, Gao TW, Zhang JZ, Wang XL, Wang J, Yang RY, Liang L, Yu JB, Zuo XB, Zhang SQ, Zhang SM, Chen G, Zheng XD, Li P, Zhu J, Li YW, Wei XD, Hong WS, Ye Y, Zhang Y, Wu WS, Cheng H, Dong PL, Hu DY, Li Y, Li M, Zhang X, Tang HY, Tang XF, Xu SX, He SM, Lv YM, Shen M, Jiang HQ, Wang Y, Li K, Kang XJ, Liu YQ, Sun L, Liu ZF, Xie SQ, Zhu CY, Xu Q, Gao JP, Hu WL, Ni C, Pan TM, Li Y, Yao S, He CF, Liu YS, Yu ZY, Yin XY, Zhang FY, Yang S, Zhou Y, Zhang XJ. Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet. 2010 Jul;42(7):614-8.

Guan C, Lin F, Zhou M, Hong W, Fu L, Xu W, Liu D, Wan Y, Xu A. The role of VIT1/FBXO11 in the regulation of apoptosis and tyrosinase export from endoplasmic reticulum in cultured melanocytes. Int J Mol Med. 2010 Jul;26(1):57-65.

Xiang W, Xu A, Xu J, Bi Z, Shang Y, Ren Q. In vivo confocal laser scanning microscopy of hypopigmented macules: a preliminary comparison of confocal images in vitiligo, nevus depigmentosus and postinflammatory hypopigmentation. Lasers Med Sci. 2010 Jul;25(4):551-8.

Natarajan VT, Singh A, Kumar AA, Sharma P, Kar HK, Marrot L, Meunier JR, Natarajan K, Rani R, Gokhale RS. Transcriptional Upregulation of Nrf2-Dependent Phase II Detoxification Genes in the Involved Epidermis of Vitiligo Vulgaris. J Invest Dermatol. 2010 Jul 22.


JUNE 2010

Choi HR, Shin JW, Lee HK, Kim JY, Huh CH, Youn SW, Park KC. Potential redox-sensitive Akt activation by dopamine activates Bad and promotes cell death in melanocytes. Oxid Med Cell Longev. 2010 May-Jun;3(3):219-24.

Zhao M, Gao F, Wu X, Tang J, Lu Q. Abnormal DNA methylation in peripheral blood mononuclear cells from patients with vitiligo. Br J Dermatol. 2010 Jun 19.

Jin Y, Birlea SA, Fain PR, Mailloux CM, Riccardi SL, Gowan K, Holland PJ, Bennett DC, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Spritz RA. Common variants in FOXP1 are associated with generalized vitiligo. Nat Genet. 2010 Jun 6.

Quan C, Ren YQ, Xiang LH, Sun LD, Xu AE, Gao XH, Chen HD, Pu XM, Wu RN, Liang CZ, Li JB, Gao TW, Zhang JZ, Wang XL, Wang J, Yang RY, Liang L, Yu JB, Zuo XB, Zhang SQ, Zhang SM, Chen G, Zheng XD, Li P, Zhu J, Li YW, Wei XD, Hong WS, Ye Y, Zhang Y, Wu WS, Cheng H, Dong PL, Hu DY, Li Y, Li M, Zhang X, Tang HY, Tang XF, Xu SX, He SM, Lv YM, Shen M, Jiang HQ, Wang Y, Li K, Kang XJ, Liu YQ, Sun L, Liu ZF, Xie SQ, Zhu CY, Xu Q, Gao JP, Hu WL, Ni C, Pan TM, Li Y, Yao S, He CF, Liu YS, Yu ZY, Yin XY, Zhang FY, Yang S, Zhou Y, Zhang XJ. Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet. 2010 Jun 6.

Silverberg JI, Silverberg AI, Malka E, Silverberg NB. A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris. J Am Acad Dermatol. 2010 Jun;62(6):937-41.

van Geel NA, Mollet IG, De Schepper S, Tjin EP, Vermaelen K, Clark RA, Kupper TS, Luiten RM, Lambert J. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi. Pigment Cell Melanoma Res. 2010 Jun;23(3):375-84.


MAY 2010

Cho EA, Lee MA, Kang H, Lee SD, Kim HO, Park YM. Vitiligo-like Depigmentation Associated with Metastatic Melanoma of an Unknown Origin. Ann Dermatol. 2009 May;21(2):178-81.

Yun JY, Uhm YK, Kim HJ, Lim SH, Chung JH, Shin MK, Yim SV, Lee MH. Transforming growth factor beta receptor II (TGFBR2) polymorphisms and the association with nonsegmental vitiligo in the Korean population. Int J Immunogenet. 2010 May 27.

Song HJ, Choi GS, Shin JH. Preservation of melanoblasts of white hair follicles of segmental vitiligo lesions: A preliminary study. J Eur Acad Dermatol Venereol. 2010 May 17.

Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Mailloux CM, Sufit AJ, Hutton SM, Amadi-Myers A, Bennett DC, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Spritz RA. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med. 2010 May 6;362(18):1686-97. Epub 2010 Apr 21.


APRIL 2010

Kim NH, Lee AY. Reduced Aquaporin3 Expression and Survival of Keratinocytes in the Depigmented Epidermis of Vitiligo. J Invest Dermatol. 2010 Apr 29.

Deeba F, Syed R, Quareen J, Waheed M, Jamil K, Rao H. Ctla-4 a49g gene polymorphism is not associated with vitiligo in South Indian population. Indian J Dermatol. 2010;55(1):29-32.

Jalel A, Ridha A, Laurent D, Philippe M, Hamdaoui MH. Impact of hla-g in the outcome of vitiligo in tunisian patients. Indian J Dermatol. 2010;55(1):25-8.

Eskandani M, Golchai J, Pirooznia N, Hasannia S. Oxidative stress level and tyrosinase activity in vitiligo patients. Indian J Dermatol. 2010;55(1):15-9.

Philips MA, Kingo K, Karelson M, Rätsep R, Aunin E, Reimann E, Reemann P, Porosaar O, Vikeså J, Nielsen FC, Vasar E, Silm H, Kõks S. Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1. BMC Med Genet. 2010 Apr 8;11:56.

Klarquist J, Denman CJ, Hernandez C, Wainwright DJ, Strickland FM, Overbeck A, Mehrotra S, Nishimura MI, Le Poole IC. Reduced skin homing by functional Treg in vitiligo. Pigment Cell Melanoma Res. 2010 Apr;23(2):276-86.


MARCH 2010

Agretti P, De Marco G, Sansone D, Betterle C, Coco G, Dimida A, Ferrarini E, Pinchera A, Vitti P, Tonacchera M. PATIENTS AFFECTED BY VITILIGO AND AUTOIMMUNE DISEASES DO NOT SHOW ANTIBODIES INTERFERING WITH THE ACTIVITY OF THE MELANOCORTIN 1 RECEPTOR. J Endocrinol Invest. 2010 Mar 22.

Manosroi J, Khositsuntiwong N, Manosroi W, Götz F, Werner RG, Manosroi A. Enhancement of transdermal absorption, gene expression and stability of tyrosinase plasmid (pMEL34)-loaded elastic cationic niosomes: Potential application in vitiligo treatment. J Pharm Sci. 2010 Mar 8;99(8):3533-3541.

Aroni K, Voudouris S, Ioannidis E, Grapsa A, Kavantzas N, Patsouris E. Increased angiogenesis and mast cells in the centre compared to the periphery of vitiligo lesions. Arch Dermatol Res. 2010 Mar 5.

Aslan S, Serarslan G, Teksoz E, Dagli S. Audiological and transient evoked otoacoustic emission findings in patients with vitiligo. Otolaryngol Head Neck Surg. 2010 Mar;142(3):409-14.

Xu S, Zhou Y, Yang S, Ren Y, Zhang C, Quan C, Gao M, He C, Chen H, Hhan J, Chen J, Liang Y, Yang J, Sun L, Yin X, Liu J, Zhang X. Platelet-derived growth factor receptor alpha gene mutations in vitiligo vulgaris. Acta Derm Venereol. 2010 Mar;90(2):131-5.


FEBRUARY 2010

de Castro CC, do Nascimento LM, Walker G, Werneck RI, Nogoceke E, Mira MT. Genetic Variants of the DDR1 Gene Are Associated with Vitiligo in Two Independent Brazilian Population Samples. J Invest Dermatol. 2010 Feb 25.

Xiang W, Xu A, Xu J, Bi Z, Shang Y, Ren Q. In vivo confocal laser scanning microscopy of hypopigmented macules: a preliminary comparison of confocal images in vitiligo, nevus depigmentosus and postinflammatory hypopigmentation. Lasers Med Sci. 2010 Feb 24.

Klarquist J, Denman CJ, Hernandez C, Wainwright DJ, Strickland FM, Overbeck A, Mehrotra S, Nishimura MI, Le Poole IC. REDUCED SKIN HOMING BY FUNCTIONAL TREG IN VITILIGO. Pigment Cell Melanoma Res. 2010 Feb 19.

Jeong TJ, Shin MK, Uhm YK, Kim HJ, Chung JH, Lee MH. Association of UVRAG polymorphisms with susceptibility to non-segmental vitiligo in a Korean sample. Exp Dermatol. 2010 Feb 16.

Yamanaka KI, Kakeda M, Kitagawa H, Tsuda K, Akeda T, Kurokawa I, Gabazza EC, Kupper TS, Mizutani H. 1,2,4-dihydroxyvitamin D (tacalcitol) prohibits skin T-cell infiltration. Br J Dermatol. 2010 Feb 15.

Gregg RK, Nichols L, Chen Y, Lu B, Engelhard VH. Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice. J Immunol. 2010 Feb 15;184(4):1909-17. Epub 2010 Jan 18.


JANUARY 2010

Becatti M, Prignano F, Fiorillo C, Pescitelli L, Nassi P, Lotti T, Taddei N. The involvement of Smac/DIABLO, p53, NF-kB and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligo skin: protective effects of curcumin and capsaicin. Antioxid Redox Signal. 2010 Jan 19.

Gregg RK, Nichols L, Chen Y, Lu B, Engelhard VH. Mechanisms of Spatial and Temporal Development of Autoimmune Vitiligo in Tyrosinase-Specific TCR Transgenic Mice. J Immunol. 2010 Jan 18.

Kostyuk V, Potapovich A, Cesareo E, Brescia S, Guerra L, Valacchi G, Pecorelli A, Raskovic D, De Luca C, Pastore S, Korkina L. Dysfunction of Glutathione S-Transferase Leads to Excess 4-Hydroxy-2-Nonenal and H2O2 and Impaired Cytokine Pattern in Cultured Keratinocytes and Blood of Vitiligo Patients. Antioxid Redox Signal. 2010 Jan 13.

Ali R, Shamsul Ahsan M, Azad MA, Ashik Ullah M, Bari W, Nazrul Islam S, Yeasmin S, Hasnat A. Immunoglobulin levels of Vitiligo patients. Pak J Pharm Sci. 2010 Jan;23(4):97-102.

Dell'anna ML, Ottaviani M, Bellei B, Albanesi V, Cossarizza A, Rossi L, Picardo M. Membrane lipid defects are responsible for the generation of reactive oxygen species in peripheral blood mononuclear cells from vitiligo patients. J Cell Physiol. 2010 Jan 4;223(1):187-193.


Return to top of page